"Lithium-induced renal disease is characterised by a progressive decline in renal function secondary to (or associated with) lithium therapy 5. There is a risk of progression to end-stage renal disease (ESRD)."
"Patients present with signs and symptoms of slowly progressive chronic kidney disease (in ~40%; range 21-55%) or diabetes insipidus (in ~25%; range 12-40%) 4,5. Approximately 1.5% of patients on long-term (>15-20 years) lithium treatment develop end-stage renal disease 4,5."
"Patients present with signs and symptoms of slowly progressive chronic kidney disease (in ~40%; range 21-55%) or diabetes insipidus (in ~25%; range 12-40%) 4,5. Approximately 1.5% of patients on long-term (>15-20 years) lithium treatment develop end-stage renal disease 4,5."